By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) 

3701 Market Street
4th Floor
Philadelphia  Pennsylvania  19104  U.S.A.
Phone: 215-966-6176 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Inovio Biomedical Corporation (INO) Closes Merger with VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) to Form a Leading Vaccine Discovery, Development and Delivery Company 6/2/2009 9:03:35 AM
Inovio Biomedical Corporation (INO)'s Registration Statement in Connection with Proposed Merger with VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Declared Effective 5/4/2009 9:21:20 AM
Inovio Biomedical Corporation (INO) and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Extend Completion Date for Definitive Merger Agreement 4/1/2009 10:14:16 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.)’ Oral Anti-Inflammatory Drug Safe in Phase I Study 3/26/2009 10:23:58 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Announces Agreement With the PATH Malaria Vaccine Initiative 3/23/2009 10:00:24 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Avian Influenza DNA Vaccine Delivered with Electroporation Provides 100% Protection of Non-Human Primates 2/23/2009 11:34:43 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors 2/18/2009 9:44:54 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Announces Filing of Device Master File Amendment with the FDA for CELLECTRA Device – Intradermal Electroporation (ID-EP) 2/13/2009 10:54:27 AM
Inovio Biomedical Corporation (INO) and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Amend Merger Agreement 12/8/2008 10:55:10 AM
Inovio Biomedical Corporation (INO) and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) to Highlight Recent Advances in Electroporation-Delivered DVA Vaccines at International DNA Vaccines Conference 12/4/2008 9:28:14 AM
12345
//-->